Cardiovascular Disease Diagnostics - A World Market Intelligence Report
NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Cardiovascular Disease Diagnostics - A World Market Intelligence Report
World cardiovascular disease diagnostics market is primarily driven by development of enhanced diagnostics systems and procedures. Rising costs of materials and growing complexity of procedures characterize the field of cardiology today. Cardiovascular disease continues to remain the leading cause behind global mortality, resulting in tens of millions of deaths per annum. With the introduction of improved diagnostics, acute and chronic medications and surgical techniques, there has been a significant plunge in total cardiovascular disease mortality over the past few decades.
Worldwide cardiac diagnostic medical device market features intense competition triggered by rapid technology advancements and development initiatives. Increasing acceptance of Computed Tomography and Magnetic Resonance angiography is expected to modify cath-lab function. Today's cardiologists can contemplate the benefits of emerging 256-slice CT scanner technology. Imaging technologies are non-invasive and provide quicker diagnosis, which not only negates the requirement of invasive diagnostic techniques but also helps in early detection of the disease, especially in case of patients complaining undiagnosed acute chest pain.
These and other market data and trends are presented in "Cardiovascular Disease Diagnostics: A World Market Intelligence Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
CARDIOVASCULAR DISEASE DIAGNOSTICS BMR-1011
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4
Cardiology Diagnostic Imaging: Future Outlook 4
Heart - Facts and Figures 5
Swift Growth in Cardiovascular Disease Devices Market 5
Cardiovascular Diseases Damaging Human Health 6
Mounting Healthcare Costs- "A Real Concern for Economies" 6
Competition in the Cardiac Diagnostics Market 6
Market Trends 7
Advancement of POC Testing Propels Cardiovascular Diagnostics
Market 7
Demand on Rise for POC Cardiac Markers 7
Minimal Invasive Procedure Hogs the Limelight of
Cardiovascular Treatment 8
Advancements in Alternate-Site Coagulation Monitoring 8
Novel Imaging Techniques Boost In vivo Diagnostic Market 8
Strong Demand for Risk Assessment Markers 9
New Technologies Bring Diagnostics Closer to Patients 9
Trends Cited in the Imaging Technologies Market 10
CT Scanners 10
MRI 11
Move Towards Efficient Patient Data Management 11
3. PRODUCT FACTS 12
4. CORPORATE DEVELOPMENTS 12
Siemens Medical acquires Dade Behring 12
Inverness Medical Innovations Acquires Cholestech 13
Acrongenomics, Pearson and Molecular Enter into Joint Venture 13
Cholestech Teams Up with Onsite Health Diagnostics 13
Lipomics to Collaborate with Agilent Technologies to Develop
Diagnostic Tests. 14
Transgenomic and Fiuotecnica Renew Collaboration Agreement 14
Alteon and BioRap Technologies Enter into an Agreement 14
IM Medical Acquires New Technology for Detecting
Cardiovascular Diseases 15
Medtronic Establishes New Business Entity 15
Siemens Medical Acquires Bayer Healthcare's Diagnostics Unit 15
Philips Rolls Out 256-slice CT scanner, Brilliance iCT Scanner 16
Royal Philips Launches Live 3D Transesophageal Echocardiogram
Probe 16
GE Healthcare Launches Vivid e Ultrasound Systems 16
Cardionetics Launches ECG Monitor for 24-Hour Real-Time
Cardiac Diagnosis 16
Siemens Launches Imaging Release for the ACUSON Sequoia Platform 17
GE Healthcare Launches Version 2.0 of Centricity Cardiology
CA1000 17
GE Healthcare Introduces New Capabilities to CardioSoft
Diagnostic Software 17
GE Healthcare's Lightspeed VCT Offers Imaging at 70% Lower
Exposure 18
Roche Diagnostics Launches cobas h 232 Portable Cardiac Marker
System (Outside US) 18
Royal Philips Launches New Imaging Tool for Complex Cardiac
Arrhythmias 18
5. MAJOR PLAYERS 19
Abbott Diagnostics (USA) 19
Biosite, Inc. (USA) 19
Cambridge Heart, Inc. (USA) 19
Cholestech Corp. (USA) 20
EP Medsystems (USA) 20
GE HealthCare (UK) 20
Liposcience, Inc. (USA) 20
Philips Healthcare (USA) 21
Roche Diagnostics (Switzerland) 21
Siemens Healthcare (Germany) 22
6. GLOBAL MARKET ANALYTICS 23
7. THE UNITED STATES 26
Cardio Vascular Disease (CVD) - An Overview 26
Startling facts related to Stroke in US 26
Incidence of Coronary Heart Disease 27
Mortality rate of CHD 27
Arrhythmias 28
CAD Diagnostics 28
PVD Diagnostics 28
Medicare Reimbursement Set for CPT Code 83704 28
Competitive Glance 29
Point-of-Care (POC) Diagnostic Market in the US 29
8. CANADA 31
9. JAPAN 32
10. EUROPE 33
a. France 36
b. Germany 37
c. Italy 38
d. The United Kingdom 39
e. Spain 41
f. Russia 42
g. Rest of Europe 43
11. ASIA-PACIFIC 44
Cardiovascular Market in Asia-Pacific 44
China 44
Cardiovascular Disease Patients Overview 44
Chinese Cardiovascular Disease Treatment as a Part of
Overall Health Care Industry 45
12. THE MIDDLE EAST 46
13. LATIN AMERICA 47
EXHIBITS
Table 1: Global Cardiovascular Disease Diagnostics Market by
Region for the Period 2007-2015 (Sales in US$ Million)
Table 2: Percentage Breakdown of Global Cardiovascular
Disease Diagnostics Market by Region for the Years 2008 &
2012
Table 3: Global Cardiovascular In Vitro Diagnostics Market by
Region for the Period 2007-2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Cardiovascular In
Vitro Diagnostics Market by Region for the Years 2008 & 2012
Table 5: Global Cardiovascular In Vivo Diagnostics Market by
Region for the Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Cardiovascular In Vivo
Diagnostics Market by Region for the Years 2008 & 2012
Table 7: Percentage Breakdown of Leading POC Cardiac
Manufacturer Value Sales in the US - 2004
Table 8: Cardiovascular Disease Diagnostics Market by Product
Segment in the US: 2007-2015 (Sales in US$ Million)
Table 9: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in the US for the Years
2008 & 2012
Table 10: Cardiovascular Disease Diagnostics Market by Product
Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Canada for the Years
2008 & 2012
Table 12: Cardiovascular Disease Diagnostics Market by Product
Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Japan for the Years
2008 & 2012
Table 14: Cardiovascular Disease Diagnostics Market by Region
in Europe: 2007-2015 (Sales in US$ Million)
Table 15: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Region in Europe for the Years 2008 &
2012
Table 16: Cardiovascular Disease Diagnostics Market by Product
Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Europe for the Years
2008 & 2012
Table 18: Cardiovascular Disease Diagnostics Market by Product
Segment in France: 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in France for the Years
2008 & 2012
Table 20: Cardiovascular Disease Diagnostics Market by Product
Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Germany for the Years
2008 & 2012
Table 22: Cardiovascular Disease Diagnostics Market by Product
Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 23: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Italy for the Years
2008 & 2012
Table 24: Cardiovascular Disease Diagnostics Market by Product
Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in the UK for the Years
2008 & 2012
Table 26: Cardiovascular Disease Diagnostics Market by Product
Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Spain for the Years
2008 & 2012
Table 28: Cardiovascular Disease Diagnostics Market by Product
Segment in Russia: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Russia for the Years
2008 & 2012
Table 30: Cardiovascular Disease Diagnostics Market by Product
Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 31: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Rest of Europe for
the Years 2008 & 2012
Table 32: Cardiovascular Disease Diagnostics Market by Product
Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Asia-Pacific for the
Years 2008 & 2012
Table 34: Cardiovascular Disease Diagnostics Market by Product
Segment in Middle East: 2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Middle East for the
Years 2008 & 2012
Table 36: Cardiovascular Disease Diagnostics Market by Product
Segment in Latin America: 2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Cardiovascular Disease
Diagnostics Market by Product Segment in Latin America for the
Years 2008 & 2012
COMPANIES PROFILED
To order this report:
Cardiovascular Devices Industry: Cardiovascular Disease Diagnostics - A World Market Intelligence Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article